Reviva Pharmaceuticals Holdings Inc. Ordinary Shares RVPH 深 滬
等待開盤 08-19 09:30:00 美东时间
0.5192
-0.021
-3.85%
華盛通- 最 高0.55
- 今 開0.54
- 成交量 350.91万股
- 最 低 0.488
- 昨 收 0.54
- 總市值 2426.74万
- 52周最高 4.28
- 市盈率 靜 --
- 換手率 7.51%
- 52周最低 0.30
- 委 比 99.36%
- 總股本 4673.99万
- 歷史最高 15.10
- 量 比 0.86
- 振 幅 11.48%
- 歷史最低 0.00
- 每 手 1
- 風險率 0.50%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Reviva Pharmaceuticals Advances Schizophrenia Treatment
Reviva Pharmaceuticals Holdings, Inc. ( ($RVPH) ) has released its Q2 earnings....
今天 12:11
美股大行评级 | 财报前夕，家得宝、劳氏、沃尔玛分别获大行上调目标价！瑞银下调赛富时目标价至260美元
今日重点评级关注：Craig-Hallum：维持Applied Digital"买入"评级，目标价从12美元升至23美元；HC Wainwright & Co.：维持Bitdeer Technologies"买入"评级，目标价从18美元升至19美元
今天 09:56
Reviva Pharmaceuticals Holdings shares are trading higher after the company reportedbetter-than-expected Q2 EPS results.
Reviva Pharmaceuticals Holdings shares are trading higher after the company rep...
08-15 22:54
【美股盘前】特朗普筹谋鸽派新Fed主席，美股期货涨0.5%，美元指数跌破97，英伟达新高后涨1%，美光科技涨2%
TradingKey - 6月26日周四美股盘前，美国总统特朗普酝酿三到四个下一任美联储鸽派主席，美债利率走低，美元指数跌破97关口，三大美股期货涨约0.50%，英伟达股价创新高后再涨超1%，业绩亮眼的美光科技涨2%。比特币价格守于10.7万，Cicle和Coinbase小幅下跌。
06-26 12:19
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Adial Pharmaceuticals (NASDAQ:ADIL) stock moved upwards by 19.6% to $0...
06-26 05:06
Reviva Pharmaceuticals announces public offering; shares down nearly 15%
Reviva Pharmaceuticals (NASDAQ:RVPH) plans to offer common stock or equivalents and warrants in a public offering. All securities in the offering will be sold by the company. Proceeds will support R&D...
06-26 04:28
Reviva Pharmaceuticals Holdings Announces Proposed Public Offering; No Size Or Amount Disclosed
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system
06-26 04:19
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
Reviva Pharmaceuticals Holdings, Inc. announced plans to offer shares of its common stock and warrants in a public offering, with proceeds to fund research and development, working capital, and general corporate purposes. A.G.P./Alliance Global Partners is acting as the sole placement agent. The securities are being offered under a shelf registration statement filed with the SEC. Preliminary prospectus supplements and base prospectuses are availa...
06-25 20:17
Reviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
Reviva Pharmaceuticals CEO, Laxminarayan Bhat, Ph.D., will present at the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference on June 16, 2025. The presentation will be available on-demand. Reviva focuses on developing therapies for CNS, inflammatory, and cardiometabolic diseases with two drug candidates, brilaroxazine (RP5063) and RP1208, both with granted composition of matter patents in the U.S., Europe, and other countries. Folde...
06-05 12:00
美股大行评级 | 潜在涨幅417.8%！RBC Capital上调Perspective Therapeutics目标价至16美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1136940401951563776.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• RBC Capital：维持Perspective Therapeutics(CATX)"跑赢大市"评级，目标价从15美元升至16美元</p> <p>• Canaccord Genuity：维持Taysha Gene Th
06-04 08:35
